Corbus Pharmaceuticals Strengthens Balance Sheet with up to $121 Million in New Capital
29 juil. 2020 08h05 HE
|
Corbus Pharmaceuticals Holdings, Inc.
Aggregate of $71 million of ATM proceeds executed at weighted average price of $7.70 per shareReceived $20 million first tranche from $50 million debt facility with K2 HealthVentures Cash on hand of...